InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Hahn Mark W, Chief Financial Officer. Director active across 2 companies, notably Verona Pharma plc. In total, 43 reports have been recorded. Split: 0 buy · 21 sells. Total volume traded: €17.1m. Activity tracked since 3 May 2021. The latest transaction was disclosed on 13 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hahn Mark W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations43 total
10,046 shares0Common StockSEC:0001408502-25-000008:0
11,264,968 sharesOrdinary SharesSEC:0001104659-25-097962:0
1,200,000 shares0Ordinary SharesSEC:0001104659-25-087055:0
255,696 shares0Ordinary SharesSEC:0001104659-25-074398:0
229,512 shares0Ordinary SharesSEC:0001104659-25-066766:0
400,000 shares@ US$11.400919.8% of flowOrdinary SharesSEC:0001104659-25-059403:0
32,432 shares@ US$9.52711.2% of flowOrdinary SharesSEC:0001104659-25-054266:0
162,704 shares@ US$9.30095.8% of flowOrdinary SharesSEC:0001104659-25-054266:1
204,864 shares@ US$9.33147.2% of flowOrdinary SharesSEC:0001104659-25-054266:2
108,272 shares@ US$8.95024.7% of flowOrdinary SharesSEC:0001104659-25-044536:0
229,512 shares0Ordinary SharesSEC:0001104659-25-043645:0
200,000 shares0Ordinary SharesSEC:0001104659-25-009142:0
58,184 shares@ US$5.00131.5% of flowOrdinary SharesSEC:0001104659-24-126371:0
12,936 shares@ US$5.000.3% of flowOrdinary SharesSEC:0001104659-24-124757:0
1,600 shares@ US$5.000.0% of flowOrdinary SharesSEC:0001104659-24-123211:0
2,400 shares@ US$5.000.1% of flowOrdinary SharesSEC:0001104659-24-117791:0
48,888 shares@ US$4.37611.1% of flowOrdinary SharesSEC:0001104659-24-114409:0
800,000 shares0Ordinary SharesSEC:0001104659-24-113576:0
141,360 shares@ US$4.37723.1% of flowOrdinary SharesSEC:0001104659-24-111567:0
249,728 shares@ US$4.38075.5% of flowOrdinary SharesSEC:0001104659-24-110658:0
600,000 shares@ US$3.756811.2% of flowOrdinary SharesSEC:0001104659-24-099790:0
1,600 shares@ US$3.130.0% of flowOrdinary SharesSEC:0001104659-24-089639:0
800,000 shares0Ordinary SharesSEC:0001104659-24-087926:0
88,544 shares@ US$2.83251.3% of flowOrdinary SharesSEC:0001104659-24-086003:0
88,544 shares@ US$1.93130.9% of flowOrdinary SharesSEC:0001104659-24-057115:0
25 of 43 declarations
About Hahn Mark W
Hahn Mark W is Directeur Financier. He is associated with Verona Pharma plc, where he is Chief Financial Officer, and with Soleno Therapeutics INC, where he is Director. His 43 filings cover transactions from 2021-05-05 to 2025-10-14, and within the recent sampled filings the sales total 17109587 EUR and purchases 0 EUR, with the dominant transaction nature indicated as Cession.
